Is it worth the risk?

By World Courier

The pharmaceutical supply chain is subject to many types of risk, among them the introduction of counterfeit products, poor planning of inventory levels and delays to distribution. Product quality in the cold chain is also a key consideration. There is a perception in the industry that as outsourcing becomes more prevalent these risks are becoming harder to control. Sue Lee of World Courier looks at risk-mitigation strategies that pharmaceutical companies can deploy to maintain control of increasingly complex and globalised supply chains.

Enter your details below to view the free white paper

By downloading this White Paper, you acknowledge that may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Visit our Privacy Policy for more information about our services, how Business Trade Media International Limited may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.